Primary sclerosing cholangitis
MONDO:0013433Primary sclerosing cholangitis (PSC) is a rare, slowly progressive liver disease characterized by inflammation and destruction of the intra- and/or extra-hepatic bile ducts that lead to cholestasis, liver fibrosis, liver cirrhosis and ultimately liver failure.
Also known as: PSC, cholangitis, primary sclerosing
70 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThis study tests whether oral vancomycin, an antibiotic, can help children aged 6-15 with inflammatory bowel disease (IBD), especially types linked to liver problems. About 140 kids will either get vancomycin plus standard care or standard care alone for up to a year. Researchers…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Poop pills could tame rare liver disease
Disease control Not yet recruitingThis study tests whether fecal microbiota transplantation (FMT) can improve liver function in people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). 72 participants will receive either FMT or a sham procedure via colonoscopy and later oral capsules…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Old antibiotic, new hope? vancomycin trial for UC and PSC
Disease control Not yet recruitingThis pilot study tests whether the antibiotic vancomycin can safely treat active ulcerative colitis in adults who also have primary sclerosing cholangitis, a liver condition. Fourteen participants will take vancomycin or a placebo for 4 weeks, with an optional 4-week extension. T…
Phase: PHASE2 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New blood test method for liver disease could make diagnosis easier
Diagnosis Not yet recruitingThis study checks if a simpler way to collect blood samples works as well as the standard method for the HepQuant DuO liver test. The test involves drinking a natural substance and taking blood samples 20 and 60 minutes later. Researchers will compare different blood collection t…
Sponsor: HepQuant, LLC • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New scan may spot liver scarring without needle biopsy
Diagnosis Not yet recruitingThis study tests whether a combined PET/MRI scan can detect and measure liver scarring (fibrosis) in people with primary sclerosing cholangitis (PSC). Ten participants will receive two experimental tracers that bind to scar tissue, and results will be compared to standard tests l…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Oxygen flow study aims to boost safety during bladder scope sedation
Knowledge-focused Not yet recruitingThis study looks at how different rates of high-flow oxygen affect oxygen levels in the blood and brain during sedation for a bladder scope procedure (cystoscopy). About 200 adults will be randomly assigned to receive one of three oxygen flow rates while their breathing and oxyge…
Phase: NA • Sponsor: Firat University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
1,000 patients to help unlock secrets of liver surgery recovery
Knowledge-focused Not yet recruitingThis study will follow 1,000 adults who have liver or bile duct surgery at one hospital in Italy. Researchers will track complications, survival, and cancer recurrence for up to 5 years. The goal is to better understand what affects recovery and long-term health after these opera…
Sponsor: Azienda USL Toscana Centro • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
30,000 blood samples could revolutionize rapid disease testing
Knowledge-focused Not yet recruitingThis study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…
Sponsor: LumiraDx UK Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New study to track hidden salt and mineral imbalances in sick kids
Knowledge-focused Not yet recruitingThis study will look at 150 infants and children aged 1 month to 4 years who are admitted to a hospital gastroenterology unit with a gastrointestinal disease. The goal is to find out how common electrolyte disturbances (like low sodium or potassium) are in these children. By meas…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:41 UTC